These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 12813982)

  • 41. Periprocedural management of anticoagulation in patients on extended warfarin therapy.
    Jafri SM; Mehta TP
    Semin Thromb Hemost; 2004 Dec; 30(6):657-64. PubMed ID: 15630672
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is computer-assisted, long-term warfarin therapy safe and efficacious for patients with nonrheumatic atrial fibrillation?
    Perez-Gomez F
    Nat Clin Pract Cardiovasc Med; 2005 Feb; 2(2):82-3. PubMed ID: 16265377
    [No Abstract]   [Full Text] [Related]  

  • 43. [Monitoring of coagulation during treatment with direct oral anticoagulants].
    Kasper A; Lindhoff-Last E
    Dtsch Med Wochenschr; 2013 Oct; 138(40):1997-2000. PubMed ID: 24065404
    [No Abstract]   [Full Text] [Related]  

  • 44. Once atrial fibrillation, always oral anticoagulation?
    Verheugt FW
    Thromb Res; 2007; 119(3):275-6. PubMed ID: 16426666
    [No Abstract]   [Full Text] [Related]  

  • 45. Anticoagulation interruptus: not without risk.
    Ezekowitz MD
    Circulation; 2004 Sep; 110(12):1518-9. PubMed ID: 15381656
    [No Abstract]   [Full Text] [Related]  

  • 46. Warfarin: better the devil you know.
    Blockman M
    Cardiovasc J Afr; 2017; 28(6):344-345. PubMed ID: 29297543
    [No Abstract]   [Full Text] [Related]  

  • 47. Improving the quality of anticoagulant therapy in patients with mechanical heart valves: what are we waiting for?
    Herijgers P; Verhamme P
    Eur Heart J; 2007 Oct; 28(20):2424-6. PubMed ID: 17890728
    [No Abstract]   [Full Text] [Related]  

  • 48. Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients.
    Torn M; Cannegieter SC; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
    Arch Intern Med; 2009 Jul; 169(13):1203-9. PubMed ID: 19597069
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Oral anticoagulation. What is vital in blood coagulation management? (interview by Dr. Judith Neumaier)].
    Sucker C
    MMW Fortschr Med; 2009 Mar; 151(12):48. PubMed ID: 19475860
    [No Abstract]   [Full Text] [Related]  

  • 50. Self-management of oral anticoagulation in nonvalvular atrial fibrillation (SMAAF study).
    Völler H; Glatz J; Taborski U; Bernardo A; Dovifat C; Heidinger K
    Z Kardiol; 2005 Mar; 94(3):182-6. PubMed ID: 15747040
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mechanical valve anticoagulation--between Scylla and Charybdis.
    Ståhle E
    Scand Cardiovasc J; 2001 Mar; 35(2):69-71. PubMed ID: 11405498
    [No Abstract]   [Full Text] [Related]  

  • 52. Oral anticoagulant therapy in patients with atrial fibrillation.
    Pengo V
    Semin Vasc Med; 2003 Aug; 3(3):333-8. PubMed ID: 15199467
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Outpatient anticoagulation].
    Pötzsch B
    MMW Fortschr Med; 2014 May; 156(9):48-53; quiz 54-5. PubMed ID: 24908890
    [No Abstract]   [Full Text] [Related]  

  • 54. New oral anticoagulants in atrial fibrillation.
    Turpie AG
    Eur Heart J; 2008 Jan; 29(2):155-65. PubMed ID: 18096568
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.
    Mant JW
    Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531
    [No Abstract]   [Full Text] [Related]  

  • 56. Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II.
    Koertke H; Zittermann A; Tenderich G; Wagner O; El-Arousy M; Krian A; Ennker J; Taborski U; Klövekorn WP; Moosdorf R; Saggau W; Koerfer R
    Eur Heart J; 2007 Oct; 28(20):2479-84. PubMed ID: 17890730
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Long-term anticoagulation in atrial fibrillation. Individualized therapy in the era of new oral anticoagulants].
    Füeßl HS
    MMW Fortschr Med; 2014 Oct; 156(18):22-4. PubMed ID: 25464533
    [No Abstract]   [Full Text] [Related]  

  • 58. Between the Devil and the Deep Blue Sea--balancing the risks and potential benefits of warfarin for older people with atrial fibrillation.
    Morgan SV
    Age Ageing; 2004 Nov; 33(6):544-7. PubMed ID: 15501835
    [No Abstract]   [Full Text] [Related]  

  • 59. Hemorrhagic complications of anticoagulant therapy.
    Levine MN; Hirsh J
    Semin Thromb Hemost; 1986 Jan; 12(1):39-57. PubMed ID: 3515558
    [No Abstract]   [Full Text] [Related]  

  • 60. The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.
    Singer DE; Fang MC; Go AS
    Arch Intern Med; 2009 Nov; 169(21):2032; author reply 2033. PubMed ID: 19933969
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.